Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake

Neuroendocrine differentiation (NED) of prostate cancer represents an acknowledged predictor of resistant and more aggressive disease. NED can be functionally exploited in vivo using PET/CT imaging with somatostatin analogs radiolabeled with 68Ga. Many previous reports have shown that 18F-FDG PET/CT...

Full description

Bibliographic Details
Main Authors: Matteo Bauckneht, Silvia Morbelli, Alberto Miceli, Sara Elena Rebuzzi, Giuseppe Fornarini
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/3/468
_version_ 1797412537514328064
author Matteo Bauckneht
Silvia Morbelli
Alberto Miceli
Sara Elena Rebuzzi
Giuseppe Fornarini
author_facet Matteo Bauckneht
Silvia Morbelli
Alberto Miceli
Sara Elena Rebuzzi
Giuseppe Fornarini
author_sort Matteo Bauckneht
collection DOAJ
description Neuroendocrine differentiation (NED) of prostate cancer represents an acknowledged predictor of resistant and more aggressive disease. NED can be functionally exploited in vivo using PET/CT imaging with somatostatin analogs radiolabeled with 68Ga. Many previous reports have shown that 18F-FDG PET/CT should also be used in cases such as guiding management, as NED is systematically associated with increased glycolysis. We hereby discuss the case of a metastatic prostate cancer patient in which 68Ga-Dotatoc PET/CT revealed the occurrence of NED with low FDG-avidity.
first_indexed 2024-03-09T05:04:26Z
format Article
id doaj.art-d55a928950384b84a0a60da59feb017a
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T05:04:26Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-d55a928950384b84a0a60da59feb017a2023-12-03T12:57:07ZengMDPI AGDiagnostics2075-44182021-03-0111346810.3390/diagnostics11030468Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG UptakeMatteo Bauckneht0Silvia Morbelli1Alberto Miceli2Sara Elena Rebuzzi3Giuseppe Fornarini4Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genova, ItalyNuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genova, ItalyDepartment of Health Sciences (DISSAL), University of Genova, 16132 Genova, ItalyMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genova, ItalyMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genova, ItalyNeuroendocrine differentiation (NED) of prostate cancer represents an acknowledged predictor of resistant and more aggressive disease. NED can be functionally exploited in vivo using PET/CT imaging with somatostatin analogs radiolabeled with 68Ga. Many previous reports have shown that 18F-FDG PET/CT should also be used in cases such as guiding management, as NED is systematically associated with increased glycolysis. We hereby discuss the case of a metastatic prostate cancer patient in which 68Ga-Dotatoc PET/CT revealed the occurrence of NED with low FDG-avidity.https://www.mdpi.com/2075-4418/11/3/468metastatic castration-resistant prostate cancerneuroendocrine differentiationpositron emission tomography18F-Fluorodeoxyglucose68Ga-Dotatoc
spellingShingle Matteo Bauckneht
Silvia Morbelli
Alberto Miceli
Sara Elena Rebuzzi
Giuseppe Fornarini
Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
Diagnostics
metastatic castration-resistant prostate cancer
neuroendocrine differentiation
positron emission tomography
18F-Fluorodeoxyglucose
68Ga-Dotatoc
title Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
title_full Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
title_fullStr Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
title_full_unstemmed Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
title_short Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
title_sort neuroendocrine differentiation of prostate cancer is not systematically associated with increased 18f fdg uptake
topic metastatic castration-resistant prostate cancer
neuroendocrine differentiation
positron emission tomography
18F-Fluorodeoxyglucose
68Ga-Dotatoc
url https://www.mdpi.com/2075-4418/11/3/468
work_keys_str_mv AT matteobauckneht neuroendocrinedifferentiationofprostatecancerisnotsystematicallyassociatedwithincreased18ffdguptake
AT silviamorbelli neuroendocrinedifferentiationofprostatecancerisnotsystematicallyassociatedwithincreased18ffdguptake
AT albertomiceli neuroendocrinedifferentiationofprostatecancerisnotsystematicallyassociatedwithincreased18ffdguptake
AT saraelenarebuzzi neuroendocrinedifferentiationofprostatecancerisnotsystematicallyassociatedwithincreased18ffdguptake
AT giuseppefornarini neuroendocrinedifferentiationofprostatecancerisnotsystematicallyassociatedwithincreased18ffdguptake